Design, Synthesis, Biological Evaluation and Pharmacokinetics of Bis(hydroxyphenyl) substituted Azoles, Thiophenes, Benzenes, and Aza-Benzenes as Potent and Selective Nonsteroidal Inhibitors of 17 beta-Hydroxysteroid Dehydrogenase Type 1 (17 beta-HSD1)

Pharmaceutical and Medicinal Chemistry, Saarland University, PO Box 15 11 50, D-66041, Saarbrucken, Germany.
Journal of Medicinal Chemistry (Impact Factor: 5.48). 11/2008; 51(21):6725-39. DOI: 10.1021/jm8006917
Source: PubMed

ABSTRACT 17beta-Estradiol (E2), the most potent female sex hormone, stimulates the growth of mammary tumors and endometriosis via activation of the estrogen receptor alpha (ERalpha). 17beta-Hydroxysteroid dehydrogenase type 1 (17beta-HSD1), which is responsible for the catalytic reduction of the weakly active estrogen estrone (E1) into E2, is therefore discussed as a novel drug target. Recently, we have discovered a 2,5-bis(hydroxyphenyl) oxazole to be a potent inhibitor of 17beta-HSD1. In this paper, further structural optimizations were performed: 39 bis(hydroxyphenyl) azoles, thiophenes, benzenes, and aza-benzenes were synthesized and their biological properties were evaluated. The most promising compounds of this study show enhanced IC 50 values in the low nanomolar range, a high selectivity toward 17beta-HSD2, a low binding affinity to ERalpha, a good metabolic stability in rat liver microsomes, and a reasonable pharmacokinetic profile after peroral application. Calculation of the molecular electrostatic potentials revealed a correlation between 17beta-HSD1 inhibition and the electron density distribution.

Download full-text


Available from: Yaseen A. Al-Soud, Apr 07, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: 17β-Hydroxysteroid dehydrogenase type 2 (17β-HSD2) catalyzes the oxidation of the highly potent steroids: the estrogen estradiol (E2) and the androgen testosterone (T) to the less active estrone and androstenedione, respectively. Inhibition of this enzyme may help maintain the local E2 level in bone tissue when the circulating E2 level drops and is therefore a novel and promising approach for the treatment of osteoporosis. In this work, a series of new nonsteroidal and achiral 17β-HSD2 inhibitors, namely N-benzyl-diphenyl-3(or 4)-carboxamide and N-benzyl-5-phenyl-thiophene-2-carboxamide was designed and the compounds were synthesized in a two to three steps reaction. A small library was built applying parallel synthesis. Highly potent 17β-HSD2 inhibitors could be identified in the thiophene-2-carboxamide class with IC(50) in the low nanomolar range. These compounds also showed a good selectivity profile toward 17β-HSD1 and toward the estrogen receptors α and β. The most interesting 17β-HSD2 inhibitor identified in this study is the 5-(2-fluoro-3-methoxyphenyl)-N-(3-hydroxybenzyl)-N-methylthiophene-2-carboxamide 6w displaying an IC(50) of 61 nM and a selectivity factor of 73 toward 17β-HSD1.
    European Journal of Medicinal Chemistry 12/2011; 46(12):5978-90. DOI:10.1016/j.ejmech.2011.10.010 · 3.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The discovery and development of small molecules that antagonizes neuronal nicotinic acetylcholine receptors may provide new ligands for evaluation in models of depression or addiction. We discovered a small molecule, VMY-2-95, a nAChR ligand with picomolar affinity and high selectivity for α4β2 receptors. In this study, we investigated its preclinical profile in regards to solubility, lipophilicity, metabolic stability, intestinal permeability, bioavailability, and drug delivery to the rat brain. Metabolic stability of VMY-2-95•2HCl was monitored on human liver microsomes and specific activity of VMY-2-95•2HCl on substrate metabolism by CYP1A2, 2C9, 2C19, 2D6, and 3A4 was tested in a high-throughput manner. The intestinal transport of VMY-2-95•2HCl was studied through Caco-2 cell monolayer permeability. VMY-2-95•2HCl was soluble in water and chemically stable, and the apparent partition coefficient was 0.682. VMY-2-95•2HCl showed significant inhibition of CYP2C9 and 2C19, but weak or no effect on 1A2, 2D6, and 3A4. The Caco-2 cell model studies revealed that VMY-2-95•2HCl was highly permeable with efflux ratio of 1.11. VMY-2-95•2HCl achieved a maximum serum concentration of 0.56 mg/mL at 0.9 hours and was orally available with a half-life of ~9 hours. Furthermore, VMY-2-95•2HCl was detected in the rat brain after 3 mg/kg oral administration and achieved a maximal brain tissue concentration of 2.3 μg/ml within 60 minutes. Overall, the results demonstrate that VMY-2-95•2HCl has a good drug like properties and can penetrate the blood brain barrier with oral administration.
    Molecular Pharmaceutics 12/2014; DOI:10.1021/mp5003569 · 4.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: An unprecedented metal-free oxidative homodimerization of a-enolic dithioesters has been achieved for the first time at room temperature within 5–10 min. Molecular iodine promotes the S-�S coupling leading to S,S’-bis(dithioacetals), while N-chlorosuccinimide facilitates C-�C coupling to give a,a’-bis(b-oxodithioesters) in good to excellent yields. Furthermore, the newly generated a,a’-bis(boxodithioesters) have been directly employed in the synthesis of fully substituted thiophenes with a unique symmetrical substitution pattern in a one pot, two-step reaction sequence.
    Advanced Synthesis & Catalysis 01/2015; 357(2-3). DOI:10.1002/adsc.201400828 · 5.54 Impact Factor